Deutsche Biotech Innovativ Balance Sheet Health
Financial Health criteria checks 2/6
Deutsche Biotech Innovativ has a total shareholder equity of €681.4K and total debt of €0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are €2.2M and €1.5M respectively.
Key information
0%
Debt to equity ratio
€0
Debt
Interest coverage ratio | n/a |
Cash | €8.08k |
Equity | €681.40k |
Total liabilities | €1.47m |
Total assets | €2.16m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: DBI's short term assets (€8.3K) do not cover its short term liabilities (€894.2K).
Long Term Liabilities: DBI's short term assets (€8.3K) do not cover its long term liabilities (€579.7K).
Debt to Equity History and Analysis
Debt Level: DBI is debt free.
Reducing Debt: DBI had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if DBI has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if DBI has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.